genetic risk variants
Ambry Updates Hereditary Cancer Risk Panels With Eye Toward Gene-Disease Validity, Guidelines
Premium
The panels assess genes with strong disease links and clinical management guidelines, but the firm offers limited-evidence genes as an add-on option.
NCCN Adds Prostate Cancer to Genetic Risk Assessment Guidelines
The NCCN also recently updated genetic risk guidelines for colorectal, endometrial, and gastric cancers.
Experts Urge FDA, CMS to Revoke Approval, Coverage for Opioid Addiction Genetic Risk Test
A coalition of experts in addiction, genetics, and public health wrote that an opioid addiction risk test from Solvd Health's AutoGenomics business performs no better than chance.
Optithera, ELNA Medical Group, Génome Québec Partner on Saliva-Based Type 2 Diabetes Test
Optithera is developing a prognostic test to asses the risk that patients with type 2 diabetes will develop severe complications before symptoms develop.
FDA Approves AutoGenomics Test for Opioid Use Disorder Risk
The genetic test is intended to be used before exposure to oral opioid pain medications in patients being considered for a four- to 30-day prescription.
Feb 20, 2020
FDA Releases List of Evidence-Based PGx Variants
Jan 22, 2020
Quest Diagnostics Acquires Blueprint Genetics
Dec 27, 2019
Jul 10, 2019